STAT6 Recombinant Protein: A Core Transcription Factor of Th2-Type Immune Responses and a Key Target for Allergic Diseases

Author: Senior Product Manager of UA Views：22

This article focuses on the molecular characteristics and immune functions of signal transducer and activator of transcription 6 (STAT6), systematically elaborating its role as a core Th2-type immune transcription factor regulated by IL-4 and IL-13 in the pathophysiology of allergic diseases, analyzing the molecular mechanisms of the JAK-STAT6 signaling cascade from cytokine receptor binding to nuclear translocation and dephosphorylation cycling, and exploring the differential functions of STAT6 in T cells, B cells, macrophages, and dendritic cells as well as its pathogenic contributions in asthma, atopic dermatitis, and eosinophilic esophagitis.

Recent Advances
Product Information

Recent Advances

STAT6 Recombinant Protein: The Core Transcription Factor of Th2-Type Immune Responses and a Key Target in Allergic Diseases

Summary: This article focuses on the molecular characteristics and immune functions of signal transducer and activator of transcription 6 (STAT6), systematically elaborating its role in the pathophysiology of allergic diseases as the core transcription factor of IL-4- and IL-13-regulated Th2-type immunity, analyzing the molecular mechanisms of the JAK-STAT6 signaling cascade from cytokine receptor binding to nuclear translocation and dephosphorylation cycling, and discussing the differential functions of STAT6 in T cells, B cells, macrophages, and dendritic cells as well as its pathogenic contribution in asthma, atopic dermatitis, and eosinophilic esophagitis.

I. Molecular Characteristics and Family Localization of STAT6.

Signal transducer and activator of transcription 6 is a member of a family of transcription factors with similar structures and functions, which includes STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6. STAT6 is mainly regulated by IL-4 and IL-13 and acts as a transcription activator induced by T helper 2 cells. Therefore, it participates in the pathophysiological processes of various allergic diseases, such as asthma, atopic dermatitis, eosinophilic esophagitis, and food allergy. The STAT6 gene is located in the 12q13.3-q14.1 region of the chromosome, closely adjacent to the NAB2 gene encoding a transcriptional repressor; this locus arrangement suggests that the two may have a synergistic or antagonistic relationship in expression regulation.

II. Activation and Cycling Mechanisms of the JAK-STAT6 Signaling Cascade.

Activation of the STAT6 signaling pathway requires its phosphorylation and is mainly regulated by IL-4 and IL-13, but other cytokines such as IL-3, IL-15, interferon α, or growth factors such as platelet-derived growth factor can also activate it. The cascade of the STAT6 signaling pathway begins with the binding of cytokine receptors. When these cytokines bind to their receptors, Janus kinases at the cytoplasmic tail of the receptor are activated and phosphorylate conserved tyrosine residues on the receptor; this phosphorylation provides docking sites for STAT6 monomers, leading cytoplasmic STAT6 to bind to the phosphorylated receptor through its Src homology domain. This enables Jak kinases to phosphorylate the conserved tyrosine Y641 site on STAT6. The entire process from IL binding to STAT6 phosphorylation takes only 3 minutes, and this extremely rapid kinetic feature enables STAT6 to respond quickly to cytokine changes in the microenvironment.

Once phosphorylated, STAT6 forms homodimers and also translocates to the nucleus through its SH2 domain, where after its DNA-binding domain binds to specific DNA sequence motifs, it activates target gene expression. For cytoplasmic translocation of STAT6 and thus repetition of this pathway, STAT6 must be dephosphorylated in the nucleus. Molecules involved in its dephosphorylation include SH2-containing phosphatase-1 found in the nucleus and T-cell protein tyrosine phosphatase, a widely expressed tyrosine phosphatase that moves between the cytoplasm and nucleus. This complete cycle of “phosphorylation-dimerization-nuclear translocation-dephosphorylation-cytoplasmic return” ensures the reversibility and repeatability of STAT6 signaling.

III. Differential Functions of STAT6 in Immune Cells.

STAT6 is a key molecule regulating immune responses, and it is associated with the development of allergic diseases as well as with effective immunity against helminth parasites, because intact STAT6-T cell signaling is required for helminth-associated intestinal inflammation. In T cells, STAT6 regulates T cell proliferation by reducing CDKN1B expression and promotes Th2 differentiation by controlling GATA3 gene expression. STAT6 is also required for the physiological function of IL-9-secreting T cells. In B cells, STAT6 promotes immunoglobulin class switching to IgE and IgG1. The fate of activated B cells differentiating into CD23-positive activated B cells or CD23-negative plasma cells requires the opposing actions of STAT6 and interferon regulatory factor 4; the former requires STAT6 pathway activation and decreased IRF4 expression, whereas the latter requires STAT6 pathway inhibition and increased IRF4 expression. In addition, BCL-6 acts as a transcriptional repressor in B cells and T cells, especially in germinal centers, by serving as a negative regulator of STAT6-mediated promoter activation.

In macrophages, STAT6 promotes IL-4-induced M2 macrophage differentiation by regulating early growth response factor 2 and promotes IL-13-induced major histocompatibility complex class II expression. Similarly, TNF receptor-associated factor 6 acts through STAT6 in macrophages; TRAF6 binds to STAT6, reducing its ubiquitination and degradation, thereby maintaining STAT6 stability. In dendritic cells, STAT6 activation promotes the induction and differentiation of Th2 cells in lymph nodes, as well as the recruitment of Th2 cells and eosinophils to nearby tissues such as the airways under allergen stimulation. These functions across cell types together constitute the complete network by which STAT6 drives type 2 immune responses.

IV. Pathological Contributions of STAT6 in Allergic Diseases.

Asthma, allergic rhinitis, and atopic dermatitis, as well as food allergy and eosinophilic esophagitis, are considered STAT6-induced Th2 cell-mediated allergic diseases. Considering the pathophysiology of asthma, STAT6 induces Sonic hedgehog expression in airway epithelium, leading to goblet cell metaplasia and increased mucus secretion. In addition, phosphorylated STAT6 appears to be associated with Th9 cells and IL-9 production in allergen-induced airway inflammation. Similarly, recent studies have shown that STAT6 participates together with T-bet in the development of atopic dermatitis, possibly by regulating IL-9 production in CD4-positive T cells.

Eosinophilic esophagitis results from STAT6-dependent eotaxin-3 accumulation. Proton pump inhibitors block the chromatin remodeling process required for STAT6 binding, thereby activating eotaxin-3 transcription. Interestingly, pediatric patients who initially respond well to proton pump inhibitors but carry certain STAT6 variants have an increased risk of relapse after maintenance therapy. In addition, in patients with cow's milk protein allergy, histone acetylation of the STAT6 gene in B cells is increased, thereby promoting its expression. These findings indicate that STAT6 is not only a core pathogenic factor of allergic diseases, but its genetic variants and epigenetic regulation also directly affect treatment response and disease relapse risk.

V. Product Characteristics and Research Application Value of STAT6 GST Tag Protein, Human.

In basic research related to STAT6 and drug development for allergic diseases, high-quality recombinant STAT6 protein is a core tool for dissecting its DNA-binding properties, phosphorylation regulation, and protein-protein interactions. The GST tag facilitates efficient purification by glutathione affinity chromatography and can serve as a detection tag for analyses such as enzyme-linked immunosorbent assay and surface plasmon resonance. To meet the needs of STAT6 functional research and exploration of Th2-type inflammatory mechanisms, Ulab provides STAT6 GST Tag Protein, Human. This product is suitable for applications including analysis of the DNA-binding activity of STAT6 with target gene promoter sequences, research on the mechanisms of STAT6 phosphorylation and dimerization, binding analysis of STAT6 with interacting proteins such as TRAF6 and BCL-6, and screening and evaluation of STAT6-targeting inhibitors.

VI. Conclusion.

As the core transcription factor of IL-4- and IL-13-regulated Th2-type immunity, STAT6, with its complete signaling cycle from cytokine receptor binding to Y641 phosphorylation, dimerization and nuclear translocation, and then dephosphorylation and return, its differential functions in T cells, B cells, macrophages, and dendritic cells in promoting Th2 differentiation, IgE class switching, M2 polarization, and Th2 cell recruitment, and its core pathogenic contribution in asthma, atopic dermatitis, eosinophilic esophagitis, and food allergy, has become one of the most promising targets in the field of type 2 inflammatory disease therapy. From the close adjacency of the STAT6 locus to NAB2 to the blockade by proton pump inhibitors of STAT6-dependent eotaxin-3 transcription, and from the association between STAT6 variants and treatment relapse risk to the regulatory mechanism by which histone acetylation promotes its expression, STAT6 continues to drive in-depth development in the fields of mechanistic research and targeted therapy for allergic diseases. STAT6 GST Tag Protein, Human provides reliable tool support for mechanistic research on the STAT6 signaling network and targeted drug development, and will continue to facilitate innovative exploration in the field of type 2 inflammatory disease therapy.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next